IN2014DN06739A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN06739A IN2014DN06739A IN6739DEN2014A IN2014DN06739A IN 2014DN06739 A IN2014DN06739 A IN 2014DN06739A IN 6739DEN2014 A IN6739DEN2014 A IN 6739DEN2014A IN 2014DN06739 A IN2014DN06739 A IN 2014DN06739A
- Authority
- IN
- India
- Prior art keywords
- treatment
- cryotherapy
- lesions
- sequential
- relates
- Prior art date
Links
- VDJHFHXMUKFKET-UHFFFAOYSA-N Ingenol mebutate Natural products CC1CC2C(C)(C)C2C2C=C(CO)C(O)C3(O)C(OC(=O)C(C)=CC)C(C)=CC31C2=O VDJHFHXMUKFKET-UHFFFAOYSA-N 0.000 abstract 2
- 208000009621 actinic keratosis Diseases 0.000 abstract 2
- VDJHFHXMUKFKET-WDUFCVPESA-N ingenol mebutate Chemical compound C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(CO)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O VDJHFHXMUKFKET-WDUFCVPESA-N 0.000 abstract 2
- 229960002993 ingenol mebutate Drugs 0.000 abstract 2
- 238000000315 cryotherapy Methods 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Otolaryngology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261591093P | 2012-01-26 | 2012-01-26 | |
| US201361753779P | 2013-01-17 | 2013-01-17 | |
| PCT/EP2013/051435 WO2013110756A1 (en) | 2012-01-26 | 2013-01-25 | Ingenol mebutate in combination with cryotherapy for the treatment of actinic keratosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN06739A true IN2014DN06739A (enrdf_load_stackoverflow) | 2015-05-22 |
Family
ID=47681847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6739DEN2014 IN2014DN06739A (enrdf_load_stackoverflow) | 2012-01-26 | 2013-01-25 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20150025139A1 (enrdf_load_stackoverflow) |
| EP (1) | EP2806869A1 (enrdf_load_stackoverflow) |
| IN (1) | IN2014DN06739A (enrdf_load_stackoverflow) |
| WO (1) | WO2013110756A1 (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180104503A1 (en) | 2016-10-15 | 2018-04-19 | Michelle Wirtz | Cold atmospheric plasma treatment of actinic keratosis and non-melanoma skin cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2558435T (pt) * | 2010-04-16 | 2017-07-24 | Leo Pharma As | Mebutato de ingenol cristalino ortorrômbico |
-
2013
- 2013-01-25 WO PCT/EP2013/051435 patent/WO2013110756A1/en active Application Filing
- 2013-01-25 EP EP13703343.7A patent/EP2806869A1/en not_active Withdrawn
- 2013-01-25 IN IN6739DEN2014 patent/IN2014DN06739A/en unknown
-
2014
- 2014-07-28 US US14/444,787 patent/US20150025139A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2806869A1 (en) | 2014-12-03 |
| WO2013110756A1 (en) | 2013-08-01 |
| US20150025139A1 (en) | 2015-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016003129A (es) | Terapia de combinacion de anticuerpos contra el csf-1r humano y anticuerpos contralel pd-l1 humano. | |
| UA109271C2 (uk) | Комбінація фітоканабіноїдів та темозоламіду для лікування гліоми | |
| EP2991670B8 (en) | Sobetirome in the treatment of myelination diseases | |
| CL2015003704A1 (es) | Péptidos y peptidomiméticos en usos de combinación y tratamientos para la subpoblacion de pacientes con cáncer | |
| MX2020003096A (es) | Formulaciones farmaceuticas de un inhibidor de hidroxilasa de hif. | |
| EP2979657A4 (en) | MEDICAL INSTRUMENT AND MEDICAL SYSTEM | |
| AU2013312359A8 (en) | Genetically modified non-human animals and methods of use thereof | |
| TWI563685B (en) | Light source, device including light source, and/or methods of making the same | |
| EP3038474A4 (en) | Nutraceutical combination for prevention and treatment of type 2 diabetes | |
| EP3036226A4 (en) | Inhibitors of human 12/15-lipoxygenase | |
| EP4509616A3 (en) | Use of cd36 to identify cancer subjects for treatment | |
| EP3044229A4 (en) | Novel peptides and analogs for use in the treatment of oral mucositis | |
| EP3050884A4 (en) | Novel chemical compounds (variants) and the use thereof to treat oncological diseases | |
| EP3060908A4 (en) | Diagnosis and treatment of autoimmune diseases | |
| GB201602663D0 (en) | Medical instrument and application thereof | |
| GB201318170D0 (en) | Proteins with Diagnostic and Therapeutic Uses | |
| EP3081140A4 (en) | Endoscope treatment instrument | |
| EP3081183A4 (en) | Treatment instrument and treatment system | |
| EP3005935A4 (en) | Medical display device and endoscopic surgery system | |
| EP3015864A4 (en) | Biomarkers for the diagnosis and the response to treatment of pancreatic cancer | |
| FR2979346B1 (fr) | Nanocorps anti-vcam-1 | |
| PH12015500822A1 (en) | Treatment of hyperproliferative and pre-cancerous skin diseases using an inhibitor of cbp/catenin | |
| EP3045102A4 (en) | Surgical instrument and medical system | |
| EP3037032A4 (en) | Light source device and endoscope device | |
| AR082436A1 (es) | Uso de teriflunomida para tratar la esclerosis multiple |